Latest News

A company spokesperson explained that Moderna has “prioritized our pipeline and R&D investments as part of our broader cost efficiency efforts,” though the company provided no additional details about the specific discontinuations.

This new facility will replace the existing laboratory, which Minister of Agriculture and Animal Resources Mark Cyubahiro Bagabe noted has served for nearly four decades and no longer meets current needs.

The procedure demonstrates how deeply Omani and Kuwaiti medical expertise can integrate when supported by cutting-edge technology.

Through this partnership, Merck gains access to Valo’s advanced AI-powered human causal biology and discovery platforms, which the drugmaker will use to identify new disease targets and develop preclinical compounds.

The deal promises to generate up to USD90 million in savings for Gavi and participating countries over the next five years.

CARF accreditation confirms that Halfway Houses maintains a strong framework emphasizing quality, safety, and evidence-based care.

The company’s Pharma business unit led the strong performance, delivering sales growth of 32%, including 20% organic growth.

The new facility will produce molecules for medical trials. These expansions will create 200 additional jobs in Frederick and 100 more in Gaithersburg.